A multi-centre Phase IIa double-blind, placebo-controlled study to investigate the efficacy and safety of GSK3196165 in subjects with inflammatory hand osteoarthritis.

Trial Profile

A multi-centre Phase IIa double-blind, placebo-controlled study to investigate the efficacy and safety of GSK3196165 in subjects with inflammatory hand osteoarthritis.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 May 2018

At a glance

  • Drugs Otilimab (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 02 May 2018 According to a MorphoSys media release, data publication anticipated in 2018.
    • 12 Dec 2017 Status changed from active, no longer recruiting to completed.
    • 14 Sep 2017 Planned End Date changed from 6 Dec 2017 to 29 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top